BioLineRx
(NASDAQ) BLRX
BioLineRx Financials at a Glance
Market Cap
$14.35M
Revenue (TTM)
$1.40M
Net Income (TTM)
-$8.89M
EPS (TTM)
-$2.14
P/E Ratio
-1.53
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$3.09
Volume
234
Open
$3.10
Price
$3.09
Volume
234
Open
$3.10
Previous Close
$3.09
Daily Range
$3.09 - $3.10
52-Week Range
$2.15 - $5.06
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$3.09
Volume
234
Open
$3.10
Previous Close
$3.09
Daily Range
$3.09 - $3.10
52-Week Range
$2.15 - $5.06
Estimated Earnings Date
Aug 13, 2026
BLRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioLineRx
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Philip Adam Serlin, MBA, CPA
Website
www.biolinerx.comHeadquarters
Hevel Modi'in, 7177871, IL
BLRX Financials
Key Financial Metrics (TTM)
Gross Margin
74.67%
Operating Margin
-780.21%
Net Income Margin
-633.83%
Return on Equity
-47.86%
Return on Capital
-36.58%
Return on Assets
-22.97%
Earnings Yield
-65.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.35M
Shares Outstanding
4.37M
Volume
234
Avg. Volume
49.96K
Financials (TTM)
Gross Profit
$1.05M
Operating Income
-$10.92M
EBITDA
-$8.20M
Operating Cash Flow
-$7.79M
Capital Expenditure
-$31.20K
Free Cash Flow
-$7.82M
Cash & ST Invst.
$17.35M
Total Debt
$9.07M
BioLineRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$477.00K
+87.1%
Gross Profit
$382.00K
+72.9%
Gross Margin
80.08%
N/A
Market Cap
$14.35M
N/A
Market Cap/Employee
$512.50K
N/A
Employees
28
N/A
Net Income
-$2.58M
-150.3%
EBITDA
-$2.25M
-139.4%
Quarterly Fundamentals
Total Cash
$17.35M
-34.2%
Total Debt
$9.07M
-34.0%
Accounts Receivable
$1.89M
-1.6%
Inventory
$2.16M
-34.9%
Long Term Debt
$4.34M
-49.7%
Short Term Debt
$4.73M
-7.7%
Return on Assets
-22.97%
N/A
Return on Invested Capital
-43.58%
N/A
Free Cash Flow
-$2.29M
+11.8%
Operating Cash Flow
-$2.28M
+12.0%